CompletedNAResults postedLast updated 13 August 2025
What this trial tests
NA trial testing A "simple medical strategy" consisting of silver diamine fluoride (SDF) in Dental Caries in 568 participants. Completed in 7 June 2024.
Timeline
18 September 2019
Primary endpoint 7 June 2024
7 June 2024
Quick facts
Lead sponsor
Case Western Reserve University
Phase
NA
Status
Completed
Study type
INTERVENTIONAL
Allocation
randomized
Design
parallel
Masking
single
Primary purpose
treatment
Enrollment
568
Start date
18 September 2019
Primary completion
7 June 2024
Estimated completion
7 June 2024
Sites
1 location across United States
Drugs / interventions tested
A "simple medical strategy" consisting of silver diamine fluoride (SDF)
B "typical dental strategy" consisting of atraumatic restorative treatment (ART) with glass ionomer cement + Fluoride varnish (FV)
62 and older, any sex, with Dental Caries. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Caries Arrest RatePrimary· Baseline to 26 weeks
International Caries Detection and Assessment System was the standard used to identify active caries lesions by examination at baseline by calibrated dental hygienists.
ICDAS examination was then used to assess caries arrest on permanent tooth surfaces with moderate to severe lesions (ICDAS codes 3-6 with activity code 2 (active)) that received SDF or ART + FV treatment baseline. A lesion was considered arrested if, at follow-up, the activity code is 1 (inactive) or the surface is sound (code S). The mean was calculated with standard deviation for both arms.
Group
Value
95% CI
A "Simple Medical Strategy" Consisting of SDF
0.75
± 0.36
A "Typical Dental Strategy" Consisting of ART + FV
0.91
± 0.21
Caries Arrest RatePrimary· Baseline to 52 weeks
International Caries Detection and Assessment System was the standard used to identify active caries lesions by examination at baseline by calibrated dental hygienists.
ICDAS examination was then used to assess caries arrest on permanent tooth surfaces with moderate to severe lesions (ICDAS codes 3-6 with activity code 2 (active)) that received SDF or ART + FV treatment baseline. A lesion was considered arrested if, at follow-up, the activity code is 1 (inactive) or the surface is sound (code S). The mean was calculated with standard deviation for both arms.
Group
Value
95% CI
A "Simple Medical Strategy" Consisting of SDF
0.88
± 0.25
A "Typical Dental Strategy" Consisting of ART + FV
0.92
± 0.21
Tooth PainPrimary· Baseline to 26 weeks
Tooth Pain and Sensitivity were assessed using the PROMIS v.1.0 - Pain Intensity 3a (Modified for Dental). A mean pain intensity score was created for the 3-item scale and ranged from 0-4 (Had no pain - 0, Mild-1, Moderate-2, Severe-3 to Very Severe - 4) and was then collapsed to 0-2 (No pain-0, mild/moderate-1, and severe/very severe-2. Higher scores indicate more pain.
Group
Value
95% CI
A "Simple Medical Strategy" Consisting of SDF
0.27
± 0.50
A "Typical Dental Strategy" Consisting of ART + FV
0.21
± 0.44
Tooth PainPrimary· Baseline to 52 weeks
Tooth Pain and Sensitivity were assessed using the PROMIS v.1.0 - Pain Intensity 3a (Modified for Dental). A mean pain intensity score was created for the 3-item scale and ranged from 0-4 (Had no pain - 0, Mild-1, Moderate-2, Severe-3 to Very Severe - 4) and was then collapsed to 0-2 (No pain-0, mild/moderate-1, and severe/very severe-2. Higher scores indicate more pain.
Group
Value
95% CI
A "Simple Medical Strategy" Consisting of SDF
0.21
± 0.43
A "Typical Dental Strategy" Consisting of ART + FV
0.25
± 0.49
Prevention of New DecaySecondary· Baseline and 26 weeks
New decay was defined as ICDAS lesion code ≥3 (localized to extensive decay) on one or more surfaces on teeth previously not found at baseline even on surfaces that did not receive the study treatments. ICDAS examination was used to determine the count of newly decayed surfaces on teeth and the mean was calculated.
Group
Value
95% CI
A "Simple Medical Strategy" Consisting of SDF
0.94
± 2.03
A "Typical Dental Strategy" Consisting of ART + FV
0.52
± 1.46
Prevention of New DecaySecondary· Baseline to 52 weeks
New decay was defined as ICDAS lesion code ≥3 (localized to extensive decay) on one or more surfaces on teeth previously not found at baseline even on surfaces that did not receive the study treatments. ICDAS examination was used to determine the count of newly decayed surfaces on teeth and the mean was calculated.
Group
Value
95% CI
A "Simple Medical Strategy" Consisting of SDF
0.67
± 1.72
A "Typical Dental Strategy" Consisting of ART + FV
0.66
± 1.71
Oral Health Related Quality of LifeSecondary· Baseline to 26 weeks
Geriatric Oral Health Related Quality of Life (GOHRQoL) overall score is created by taking the sum of each of the 12 items, which were collected using a Likert type scale with 3 levels (Always/Often - 1, Sometimes/Seldom - 2, Never - 3). The overall scores ranged from 12-36 with higher scores indicating better quality of life. The mean was calculated for the SDF and ART groups.
Group
Value
95% CI
A "Simple Medical Strategy" Consisting of SDF
30.73
± 4.33
A "Typical Dental Strategy" Consisting of ART + FV
30.45
± 4.43
Oral Health Related Quality of LifeSecondary· Baseline to 52 weeks
Geriatric Oral Health Related Quality of Life (GOHRQoL) overall score is created by taking the sum of each of the 12 items, which were collected using a Likert type scale with 3 levels (Always/Often - 1, Sometimes/Seldom - 2, Never - 3). The overall scores ranged from 12-36 with higher scores indicating better quality of life. The mean was calculated for the SDF and ART groups.
Group
Value
95% CI
A "Simple Medical Strategy" Consisting of SDF
30.44
± 4.65
A "Typical Dental Strategy" Consisting of ART + FV
30.04
± 4.94
Adverse events — posted to ClinicalTrials.gov
Time frame: Adverse event data was collected from baseline to the 52 week follow-up..
Reporting threshold: 0%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
A "Simple Medical Strategy" Consisting of SDF
Serious: 14/346 (4%)
Deaths: 14/346
A "Typical Dental Strategy" Consisting of ART + FV
The study is a cluster randomized clinical trial (RCT) to be conducted in 40 (22 originally planned +16 additional) publicly subsidized housing facilities/sites (HUD Section 202) and other low-income housing voucher programs in NE Ohio. The facilities will be randomized to 2 arms: Arm 1 (20 sites) - Participants will receive biannual silver diamine fluoride (SDF) versus Arm 2 (20 sites): Participants will receive atraumatic restorative treatment (ART) with glass ionomer cement (GIC) + biannual fluoride varnish (FV) application. A total of 590 (550 originally planned + 40 additional) participants (Arm 1: 295, Arm 2: 295) will be followed for one year (baseline, 26 weeks, 52 weeks).
The protocol for each arm will address both coronal and root surface tooth decay lesions: Arm 1: The treatment will be bi-annual topical 38% SDF(Advantage Arrest, Elevate Oral Care LLC., West Palm Beach, FL) following manufacturer's instructions and published guidelines; Arm 2: The treatment will be ART will be a modification where the cavity will be restored with high viscosity glass-ionomer cement (GIC) (GC Fuji Automix LC Resin Reinforced Glass Ionomer Restorative, Japan)). Patients will also receive biannual topical fluoride varnish treatments (FluoriMax, Elevate) according to manufacturer's instructions.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
NCT06787261 — Involvement of Archaea in Carious Disease
· NA
· recruiting
NCT06753669 — Mothers' Action Project for Child Health
· NA
· recruiting
NCT07431463 — Effects of Different Remineralization Agents on the Progression of Non-Cavitated Approximal Carious Lesions in Primary T
· NA
· active not recruiting
NCT07134114 — Occlusal Impact of Hall Crowns in Primary Molars
· NA
· recruiting
NCT07181967 — SDF vs Fluoride Varnish for Streptococcus Mutans Reduction in Children
· NA
· recruiting
Other Case Western Reserve University trials
Trials by the same sponsor.
NCT07216950 — Knowledge and Interpersonal Skills to Develop Enhanced Relationships (KINDER)
· Phase 2
· not yet recruiting
NCT07006935 — REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)
· NA
· not yet recruiting
NCT07214233 — Youth Empowerment and Safety Intervention
· NA
· recruiting
NCT07225582 — Development of Optimal Sensory Feedback Strategies to Maximize Function After Tetraplegia
· NA
· recruiting
NCT07217249 — Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years
· NA
· enrolling by invitation
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Case Western Reserve University
Last refreshed: 13 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03916926.